{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:46:54Z","timestamp":1792464414378,"version":"4.5.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10,1]]},"DOI":"10.1093\/jac\/dkx219","type":"journal-article","created":{"date-parts":[[2017,6,12]],"date-time":"2017-06-12T11:06:50Z","timestamp":1497265610000},"page":"2817-2822","source":"Crossref","is-referenced-by-count":10,"title":["Penetration of linezolid into synovial fluid and muscle tissue after elective arthroscopy"],"prefix":"10.1093","volume":"72","author":[{"given":"R","family":"Schwameis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Syr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Sarahrudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Appelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Marhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Burau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Kloft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Zeitlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,7,24]]},"reference":[{"key":"key\n\t\t\t\t20171107085854_dkx219-B1","first-page":"1309","article-title":"[Acute joint infection\u2014diagnosis and treatment]","volume":"33","year":"2004","journal-title":"Orthopade"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B2","doi-asserted-by":"crossref","first-page":"332.","DOI":"10.1007\/s11926-013-0332-4","article-title":"Clinical management of septic arthritis","volume":"15","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B3","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0140-6736(09)61595-6","article-title":"Bacterial septic arthritis in adults","volume":"375","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.annemergmed.2009.06.511","article-title":"How common is MRSA in adult septic arthritis?","volume":"54","year":"2009","journal-title":"Ann Emerg Med"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B6","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/rheumatology\/kel163a","article-title":"BSR & BHPR, BOA, RCGP and BSAC guidelines for management of the hot swollen joint in adults","volume":"45","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1086\/346207","article-title":"Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001","volume":"36","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B8","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1128\/JCM.43.8.4156-4158.2005","article-title":"Septic arthritis caused by vancomycin-intermediate Staphylococcus aureus","volume":"43","year":"2005","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B9","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/jac\/dkf215","article-title":"The efficacy and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin","volume":"50","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B10","first-page":"396","article-title":"[Vancomycin resistant Staphylococcus epidermidis caused prosthesis infection. Linezolid and rifampicin healed the complicated infection]","volume":"111","year":"2014","journal-title":"Lakartidningen"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2165\/00003088-200039030-00001","article-title":"Clinical pharmacokinetics of teicoplanin","volume":"39","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B12","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ijantimicag.2015.01.015","article-title":"Albumin concentration significantly impacts on free teicoplanin plasma concentrations in non-critically ill patients with chronic bone sepsis","volume":"45","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.resmic.2011.12.004","article-title":"Enhanced activity of linezolid against Staphylococcus aureus in cerebrospinal fluid","volume":"163","year":"2012","journal-title":"Res Microbiol"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/00365540510036589","article-title":"Severe staphylococcal knee arthritis responding favourably to linezolid, after glycopeptide-rifampicin failure: a case report and literature review","volume":"37","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/bdd.255","article-title":"Linezolid absolute bioavailability and the effect of food on oral bioavailability","volume":"22","year":"2001","journal-title":"Biopharm Drug Dispos"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B16","first-page":"46","article-title":"Methods to measure target site penetration of antibiotics in critically ill patients","volume":"8","year":"2013","journal-title":"Curr Clin Pharmacol"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B17","author":"Committee for Medicinal Products for Human Use (CHMP), EMA"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B18","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s11095-006-9206-z","article-title":"AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives","volume":"24","year":"2007","journal-title":"Pharm Res"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0169-409X(00)00106-X","article-title":"Microdialysis in peripheral tissues","volume":"45","year":"2000","journal-title":"Adv Drug Deliv Rev"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B20","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/bmj.324.7337.588","article-title":"Science, medicine, and the future: microdialysis","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jchromb.2003.08.019","article-title":"Development of a liquid chromatography method for the determination of linezolid and its application to in vitro and human microdialysis samples","volume":"796","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B22","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jchromb.2016.06.033","article-title":"Simultaneous determination and stability studies of linezolid, meropenem and vancomycin in bacterial growth medium by high-performance liquid chromatography","volume":"1028","year":"2016","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B23","author":"Committee for Medicinal Products for Human Use (CHMP), EMA"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/bcp.12636","article-title":"Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patients","volume":"80","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B25","first-page":"173","article-title":"Effect of severity of sepsis on tissue concentrations of linezolid","volume":"61","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B26","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1128\/AAC.02112-12","article-title":"Linezolid surveillance results for the United States: LEADER surveillance program 2011","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B27","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S20","author":"Clinical and Laboratory Standards Institute","year":"2010"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B28","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1128\/AAC.49.6.2367-2371.2005","article-title":"Penetration of linezolid into soft tissues of healthy volunteers after single and multiple doses","volume":"49","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B29","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1128\/AAC.01468-05","article-title":"Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis","volume":"50","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B30","doi-asserted-by":"crossref","first-page":"i47","DOI":"10.1093\/jac\/dku252","article-title":"Clinical experience with linezolid for the treatment of orthopaedic implant infections","volume":"69","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijantimicag.2005.09.017","article-title":"The effect of food on plasma and tissue concentrations of linezolid after multiple doses","volume":"27","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B32","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/jac\/43.4.593","article-title":"Concentration and bactericidal activity of fusidic acid and cloxacillin in serum and synovial fluid","volume":"43","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B33","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/cpt1972135part1724","article-title":"Effect of protein binding on levels of ampicillin and cloxacillin in synovial fluid","volume":"13","year":"1972","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B34","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/jcph.296","article-title":"Target site pharmacokinetics of linezolid after single and multiple doses in diabetic patients with soft tissue infection","volume":"54","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B35","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s40262-016-0463-7","article-title":"Clinical determinants of target non-attainment of linezolid in plasma and interstitial space fluid: a pooled population pharmacokinetic analysis with focus on critically ill patients","volume":"56","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B36","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/jac\/dkf207","article-title":"Linezolid penetration into osteo-articular tissues","volume":"50","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.arthro.2016.05.020","article-title":"Efficacy of prophylactic antibiotics in simple knee arthroscopy","volume":"33","year":"2017","journal-title":"Arthroscopy"},{"key":"key\n\t\t\t\t20171107085854_dkx219-B38","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.arthro.2006.02.004","article-title":"Antibiotic prophylaxis for arthroscopic surgery","volume":"22","year":"2006","journal-title":"Arthroscopy"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/10\/2817\/21587546\/dkx219.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T13:59:09Z","timestamp":1510063149000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/72\/10\/2817\/4031485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,24]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,7,24]]},"published-print":{"date-parts":[[2017,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx219","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,10]]},"published":{"date-parts":[[2017,7,24]]}}}